Health and Healthcare

Merck : MRK

All Merck Articles

1087 Articles

Chris Lange | Aug 10, 2018 at 9:50 AM EDT

Short Sellers Hike Bets in Major Pharma Stocks

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 27, 2018 at 10:40 AM EDT

Merck Underwhelms Despite Beating Earnings

Merck reported better-than-expected second-quarter results before the markets opened on Friday, but shares retreated afterward.

Chris Lange | Jul 25, 2018 at 7:35 AM EDT

Major Pharma Stocks Scare Off Short Sellers

The July 13 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 22, 2018 at 10:40 AM EDT

Boeing, McDonald’s, Intel and More Dow Stocks Reporting This Week

24/7 Wall St. has put together a preview of Boeing, Exxon, Verizon and other Dow industrials scheduled to report their…

Lee Jackson | Jul 20, 2018 at 8:00 AM EDT

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Four pharmaceutical industry leaders are poised to report second-quarter results next week, and one key analyst sees the relatively good…

Chris Lange | Jul 12, 2018 at 8:50 AM EDT

Where Did Major Pharma Short Sellers Go?

The June 29 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | Jul 5, 2018 at 4:01 PM EDT

Intel, Walgreens Pace the Dow Thursday

Intel, Walgreens, Johnson & Johnson, and Merck led the Dow higher Thursday.

Chris Lange | Jul 2, 2018 at 11:10 AM EDT

FDA Accepts Merck’s Keytruda for Review, Sets PDUFA Date

Merck shares retreated to start off the week despite the announcement of good news from the FDA.

Chris Lange | Jun 27, 2018 at 1:05 PM EDT

Short Sellers Hike Bets in Major Pharma Stocks

The June 15 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Jun 20, 2018 at 10:05 AM EDT

5 Stocks to Buy Now If You Fear a Trade War Market Crash

The fear of a massive global trade war is one that has just not been part of the investing lexicon…

Paul Ausick | Jun 18, 2018 at 4:01 PM EDT

Intel, Procter & Gamble Weigh on the Dow Monday

Intel, P&G, Travelers, and Merck were Monday's worst performing Dow stocks.

Paul Ausick | Jun 14, 2018 at 4:01 PM EDT

General Electric, JPMorgan Weaken the Dow Thursday

General Electric, JPMorgan, Merck, and Coca-Cola weighed on the Dow Thursday.

Chris Lange | Jun 14, 2018 at 10:28 AM EDT

Merck Wins Another FDA Approval For Keytruda

Merck & Co., Inc. (NYSE: MRK) shares took a small step back on Thursday after the company announced a key…

Chris Lange | Jun 12, 2018 at 10:49 AM EDT

Major Pharmaceuticals Scare Off Short Sellers

Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay…

Paul Ausick | Jun 5, 2018 at 4:01 PM EDT

DowDuPont, Walmart Balance the Dow Tuesday

DowDuPont and GE were Tuesday's leading gainers among the Dow 30 stocks while Walmart and Merck, Monday's big gainers, were…

1 … 21 22 23 24 25 … 73

Merck : MRK

All Merck Articles

Short Sellers Hike Bets in Major Pharma Stocks

Merck Underwhelms Despite Beating Earnings

Major Pharma Stocks Scare Off Short Sellers

Boeing, McDonald’s, Intel and More Dow Stocks Reporting This Week

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Where Did Major Pharma Short Sellers Go?

Intel, Walgreens Pace the Dow Thursday

FDA Accepts Merck’s Keytruda for Review, Sets PDUFA Date

Short Sellers Hike Bets in Major Pharma Stocks

5 Stocks to Buy Now If You Fear a Trade War Market Crash

Intel, Procter & Gamble Weigh on the Dow Monday

General Electric, JPMorgan Weaken the Dow Thursday

Merck Wins Another FDA Approval For Keytruda

Major Pharmaceuticals Scare Off Short Sellers

DowDuPont, Walmart Balance the Dow Tuesday

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

Merck : MRK

All Merck Articles

Short Sellers Hike Bets in Major Pharma Stocks

Merck Underwhelms Despite Beating Earnings

Major Pharma Stocks Scare Off Short Sellers

Boeing, McDonald’s, Intel and More Dow Stocks Reporting This Week

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Where Did Major Pharma Short Sellers Go?

Intel, Walgreens Pace the Dow Thursday

FDA Accepts Merck’s Keytruda for Review, Sets PDUFA Date

Short Sellers Hike Bets in Major Pharma Stocks

5 Stocks to Buy Now If You Fear a Trade War Market Crash

Intel, Procter & Gamble Weigh on the Dow Monday

General Electric, JPMorgan Weaken the Dow Thursday

Merck Wins Another FDA Approval For Keytruda

Major Pharmaceuticals Scare Off Short Sellers

DowDuPont, Walmart Balance the Dow Tuesday

QQQI Yields You Almost 14%, but Can It Survive a Dot-Com-Style Recession?

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

Featured Reads

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line